Orbital implants: Potential new directions

Expert Review of Medical Devices

Volumn 3, Issue 6, 2006, Pages 805-815

  Hicks, Celia R ^a   Morrison, David ^a   Lou, Xia ^b   Crawford, Geoffrey J ^c   Gadjatsy, Adam ^d   Constable, Ian J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d Lions Eye Institute   (United States)

Author keywords

Biocolonization; Enucleation; Orbital implant

Indexed keywords

ACRYLIC ACID; ALUMINUM HYDROXIDE; ANALGESIC AGENT; HYDROXYAPATITE; POLY(METHYL METHACRYLATE); POLYETHYLENE; POLYETHYLENE TEREPHTHALATE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYMACON; ROSEOLIC ACID;

CERAMIC PROSTHESIS; ENCAPSULATION; ESTHETIC SURGERY; EYE MOVEMENT; EYE SURGERY; HUMAN; ORBIT IMPLANT; ORBIT INFECTION; POSTOPERATIVE PAIN; PROSTHESIS; PROSTHESIS FAILURE; PROSTHESIS INFECTION; PROSTHESIS MATERIAL; REVIEW; SILICONE PROSTHESIS;

EID: 33845883533     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.3.6.805     Document Type: Review

References (63)

1. Rubin PA. Enucleation, evisceration, and exenteration. Curr. Opin. Ophthalmol. 4(5), 39-48 (1993).
2. Dresner SC, Karesh JW. Primary implant placement with evisceration in patients with endophthalmitis. Ophthalmology 107(9), 1661-1664 (2000).
3. Fountain TR, Goldberger S, Murphree AL. Orbital development after enucleation in early childhood. Ophthalmol. Plast. Reconstr. Surg. 15(1), 32-36 (1999).
4. Moshfeghi DM, Moshfeghi AA, Finger PT. Enucleation. Surv. Ophthalmol. 44(4), 277-301 (2000).
5. Perry AC. Integrated orbital implants. Adv. Ophthalmol. Plast. Reconstr. Surg. 8, 75-81 (1990).
6. Dutton JJ. Coralline hydroxyapatite as an ocular implant. Ophthalmology 98, 370-377 (1991).
7. Jordan DR, Munro SM, Brownstein S, Gilberg SM, Grahovac SZ. A synthetic hydroxyapatite implant: the so-called counterfeit implant. Ophthalmol. Plast. Reconstr. Surg. 14(4), 244-249 (1998).
8. Jordan DR, Gilberg S, Mawn LA. The bioceramic orbital implant: experience with 107 implants. Ophthalmol. Plast. Reconstr. Surg. 19(2), 128-135 (2003).
9. Goldberg RA, Dresner SC, Braslow RA, Kossovsky N, Legmann A. Animal model of porous polyethylene orbital implants. Ophthalmol. Plast. Reconstr. Surg. 10(2), 104-109 (1994).
10. Anderson RL, Yen MT, Lucci LM, Caruso RT. The quasi-integrated porous polyethylene orbital implant. Ophthalmol. Plast. Reconstr. Surg. 18(1), 50-55 (2002).
11. Thaller VT. Enucleation volume measurement. Ophthalmol. Plast. Reconstr. Surg. 13(1), 18-20 (1997).
12. Kaltreider SA, Jacobs JL, Hughes MO. Predicting the ideal implant size before enucleation. Ophthalmol. Plast. Reconstr. Surg. 15(1), 37-43 (1999).
13. Hamor RE, Roberts SM, Severin GA. Use of orbital implants after enucleation in dogs, horses, and cats: 161 cases (1980-1990). J. Am. Vet. Med. Assoc. 203(5), 701-706 (1993).
14. Kao SC, Chen S. The use of rectus abdominis sheath for wrapping of the hydroxyapatite orbital implants. Ophthalmol. Surg. Lasers 30(1), 69-71 (1999).
15. Gayre GS, Debacker C, Lipham W, Tawfik HA, Holck D, Dutton JJ. Bovine pericardium as wrapping for orbital implants. Ophthalmol. Plast. Reconstr. Surg. 17(5), 381-387 (2001).
16. Klapper SR, Jordan DR, Punja K et al. Hydroxyapatite implant wrapping materials: analysis of fibrovascular ingrowth in an animal model. Ophthalmol. Plast. Reconstr. Surg. 16(4), 278-285 (2000).
17. Klapper SR, Jordan DF, Ells A, Grahovac S. Hydroxyapatite orbital implant vascularization assessed by magnetic resonance imaging. Ophthalmol. Plast. Reconstr. Surg. 19(1), 46-52 (2003).
18. Jordan DR, Brownstein S, Dorey M, Yuen VH, Gilberg S. Fibrovascularization of porous polyethylene (Medpor) orbital implant in a rabbit model. Ophthalmol. Plast. Reconstr. Surg. 20(2), 136-443 (2004).
19. De Potter P, Duprez T, Cosnard G. Postcontrast magnetic resonance imaging assessment of porous polyethylene orbital implant (Medpor). Ophthalmology 107(9), 1656-1660 (2000).
20. Sarvananthan N, Liddicoat AJ, Fahy GT. Synthetic hydroxyapatite orbital implants: a clinical and MRI evaluation. Eye 13(Pt 2), 205-208 (1999).
21. Ainbinder DJ, Haik BG, Mazzoli RA. Anophthalmic socket and orbital implants. Role of CT and MR imaging. Radiologic. Clin. N. Am. 36(6), 1133-1147 (1998).
22. Hsu WC, Green JP, Spilker MH, Rubin PA. Primary placement of a titanium motility post in a porous polyethylene orbital implant: animal model with quantitative assessment of fibrovascular ingrowth and vascular density. Ophthalmol. Plast. Reconstr. Surg. 16(5), 370-379 (2000).
23. Holck DF, Dutton JJ, Proia A et al. Rate of vascularization of coralline hydroxyapatite spherical implants pretreated with saline/gentamicin, rTGF-β2, and autogenous plasma. Qphthalmol. Plast. Reconstr. Surg. 14(2), 73-80 (1998).
24. Mawn LA, Jordan DR, Gilberg S. Proliferation of human fibroblasts in vitro after exposure to orbital implants. Can. J. Ophthalmol. 36(5), 245-251 (2001).
25. Fitton JH, Dalton BA, Beumer G, Johnson G, Griesser HJ, Steele JG. Surface topography can interfere with epithelial tissue migration. J. Biomed. Mat. Res. 42(2), 245-257 (1998).
26. Ziegelaar B, Fitton JH, Clayton AB, Platten ST, Steer J, Chirila TV. The modulation of cellular responses to poly(2-hydroxyethyl methacrylate) hydrogel surfaces: phosphorylation decreases macrophage collagenase production in vitro. J. Biomater. Sci. Polymer Edn. 9(8), 849-862 (1998).
27. Hornblass A, Biesman BS, Eviatar JA. Current techniques of enucleation: a survey of 5,439 intraorbital implants and a review of the literature. Ophthalmol. Plast Reconstr. Surg. 11(2), 77-86 (1995).
28. Shields CL, Shields JA, De Potter P, Singh AD. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases. Br. J. Ophthalmol 78(9), 702-706 (1994).
29. Su GW, Yen MT. Current trends in managing the anophthalmic socket after primary enucleation and evisceration. Ophthamol. Plast. Reconstr. Surg. 20(4), 274-280 (2004).
30. Oestreicher JH, Bashour M, Jong R, Chiu B. Aspergillus mycetoma in a secondary hydroxyapatite orbital implant: a case report and literature review. Ophthalmology 106(5), 987-991 (1999).
31. Devoto MH, Zaffaroni MC. Orbital myiasis in a patient with a chronically exposed hydroxyapatite implant. Ophthalmol, Plast. Reconstr. Surg. 20(5), 395-396 (2004).
32. Wilson MW, Wobig JL, Dailey RA. Infection of a porous polyethylene orbital implant with Capnocytophaga. Ophthalmol. Plast. Reconstr. Surg. 14(6), 398-402 (1998).
33. Lin CJ, Liao SL, Jou JR, Kao SC, Hou PK, Chen MS. Complications of motility peg placement for porous hydroxyapatite orbital implants. Br. J. Ophthalmol. 86(4), 394-396 (2002).
34. Guillinta P, Vasani SN, Granet DB, Kikkawa DO. Prosthetic motility in pegged versus unpegged integrated porous orbital implants. Ophthalmol. Plast. Reconstr. Surg. 19(2), 119-122 (2003).
35. Jordan DR, Klapper SR. A new titanium peg system for hydroxyapatite orbital implants. Ophthalmol, Plast. Reconstr. Surg. 16(5), 380-387 (2000).
36. Jordan DR. Spontaneous loosening of hydroxyapatite peg sleeves. Ophthalmology 108(11), 2041-2044 (2001).
37. Lew H, Lee SY, Yang WI, Kim SJ. A morphological study of drill holes applied with mitomycin-C in hydroxyapatite orbital implants. Ophthalmol, Res. 33(6), 340-344 (2001).
38. Fezza JP, Klippenstein KA, Wesley RE. Use of an orbital epidural catheter to control pain after orbital implant surgery. Arch. Ophthalmol. 117(6), 784-788 (1999).
39. Rubin PA, Popham J, Rumelt S et al. Enhancement of the cosmetic and functional outcome of enucleation with the conical orbital implant. Ophthalmology 105(5), 919-925 (1998).
40. Christmas NJ, Gordon CD, Murray TG et al. Intraorbital implants after enucleation and their complications: a 10-year review. Arch. Ophthalmol. 116(9), 1199-1203 (1998).
41. Trichopoulos N, Augsburger JJ. Enucleation with unwrapped porous and nonporous orbital implants: a 15-year experience. Ophthalmol. Plast. Reconstr. Surg. 21(5), 331-336 (2005).
42. Chuah CT, Chee SP, Fong KS et al. Integrated hydroxyapatite implant and non-integrated implants in enucleated Asian patients. Ann. Acad. Med. Singapore 33(4), 477-483 (2004).
43. Custer PL. Enucleation: past, present, and future. Ophthalmol. Plast. Reconstr. Surg. 16(5), 316-321 (2000).
44. Remulla HD, Rubin PA, Shore JW et al. Complications of porous spherical orbital implants. Ophthalmology 102(4), 586-593 (1995).
45. Jordan DR. Problems after evisceration surgery with porous orbital implants: experience with 86 patients. Ophthalmol. Plast. Reconstr. Surg. 20(5), 374-380 (2004).
46. Blaydon SM, Shepler TR, Neuhaus RW, White WL, Shore JW. The porous polyethylene (Medpor) spherical orbital implant: a retrospective study of 136 cases. Ophthalmol. Plast. Reconstr. Surg. 19(5), 364-371 (2003).
47. Custer PL, Kennedy RH, Woog JJ, Kaltreider SA, Meyer DR. Orbital implants in enucleation surgery: a report by the American Academy of Ophthalmology. Ophthalmology 110(10), 2054-2061 (2003).
48. Hintschich C, Zonneveld FW, Baldeschi L, Koornneef L. Long-term results of secondary orbital implants. Ophthalmologe 96(1), 34-39 (1999).
49. Hicks CR, Clayton AB, Vijayasekaran S, Crawford GJ, Chirila TV, Constable IJ. Development of a poly(2-hydroxyethyl methacrylate) orbital implant allowing direct muscle attachment and tissue ingrowth. Ophthalmol. Plast. Reconstr. Surg. 15(5), 326-332 (1999).
50. Yeatts RP, Grim W, Stanton C, Curry C. Injectable hydroxyapatite paste as an option for ocular implantation after evisceration. Ophthalmology 109(11), 2123-2128 (2002).
51. Hintschich C, Raithel E, Craig GT et al. Glass-ionomer cement: evaluation as an orbital implant. Graefes Arch. Clin. Exp. Ophthalmol. 237(2), 169-174 (1999).
52. Schellini SA, Xavier AP, Hoyama E et al. Gelatinous polyethylene in the treatment of the anophthalmic cavity. Orbit. 21(3), 189-193 (2002).
53. Jordan DR, Brownstein S, Gilberg S, Matthew B, Mawn L, Khouri L. Investigation of a bioresorbable orbital implant. Ophthalmol. Plast. Reconstr. Surg. 18(5), 342-348 (2002).
54. Mitchell KT. The autogenous dermis-fat orbital implant in children. J. Aapos: Am. Assoc. Pediatr. Ophthalmol. Strabismus 5(6), 367-369 (2001).
55. Hicks CR, Clayton AB, Vijayasekaran S et al. The development of an orbital implant allowing direct muscle attachment. In: Societas Ophthalmologica Europaea, XIth Congress of the European Society of Ophthalmology Suveges IFP (Ed.). Monduzzi Editore, Bologna, Italy, 889-893 (1997).
56. Chirila TV, Vijayasekaran S, Horne R et al. Interpenetrating polymer network (IPN) as a permanent joint between the elements of a new type of artificial cornea. J. Biomed. Mat. Res. 28(6), 745-753 (1994).
57. Hicks CR, Chirila TV, Clayton AB et al. Clinical results of implantation of the Chirila keratoprosthesis in rabbits. Br. J. Ophthalmol. 82(1), 18-25 (1998).
58. Hicks CR, Verner L, Vijayasekaran S, Mamalis N, Apple DJ. Histology of AlphaCor skirts: evaluation of biointegration. Cornea 24(8), 933-940 (2005).
59. Hicks CR. Indications and technique: AlphaCor Artificial Cornea. Techniques Ophthalmol. 1(3), 151-155 (2003).
60. Hicks CR, Datt JKG, Grabner G et al. AlphaCor: clinical outcomes. Cornea 25(9), 1034-1042 (2006).
61. Hicks CR. Macvie O, Crawford GJ, Constable IJ. A risk score as part of an evidence-based approach to the selection of corneal replacement surgery. Cornea 24(5), 523-530 (2005).
62. Hicks CR, Morris IT, Vijayasekaran S et al. Correlation of histological findings with gadolinium enhanced MRI scans during healing of a PHEMA orbital implant in rabbits. Br. J. Ophthalmol. 83(5), 616-621 (1999).
63. Labat B CA, Frey J. Effects of δ-alumina and hydroxyaspatite coatings in the growth and metabolism of human osteoblasts. J. Biomed. Mater. Res. 29, 1397-1401 (1995).